{"id":7865,"date":"2022-11-29T16:00:56","date_gmt":"2022-11-29T16:00:56","guid":{"rendered":"http:\/\/hnetalk.com\/provider\/?p=7865"},"modified":"2022-11-29T16:00:56","modified_gmt":"2022-11-29T16:00:56","slug":"formulary-update-12-22","status":"publish","type":"post","link":"http:\/\/hnetalk.com\/provider\/formulary-update-12-22\/","title":{"rendered":"Formulary Update"},"content":{"rendered":"<p>Health New England ensures our prescription drug coverage includes brand names and generic prescription medications.<\/p>\n<p>Most recently, we reviewed the following brand drugs. To learn more about the coverage, dosage and authorization requirements, reference Health New England\u2019s formularies located at <a href=\"http:\/\/healthnewengland.org\" target=\"_blank\" rel=\"noopener\">healthnewengland.org<\/a>. At the top of the page, use the \u201c<a href=\"https:\/\/healthnewengland.org\/pharmacy\/find-drug\" target=\"_blank\" rel=\"noopener\">Find A Drug<\/a>\u201d tool.<\/p>\n<p>Elepsia XR<br \/>\nIBSrela<br \/>\nIncrelex<br \/>\nTymlos<br \/>\nTeriparatide<\/p>\n<p>For additional questions, please call your Provider Relations Representative at (800) 842-4464, extension 5000, or send an email to <a href=\"mailto:providerrelations@hne.com\" target=\"_blank\" rel=\"noopener\">providerrelations@hne.com<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Health New England ensures our prescription drug coverage includes brand names and generic prescription medications. Most recently, we reviewed the following brand drugs. To learn more about the coverage, dosage and authorization requirements, reference Health New England\u2019s formularies located at healthnewengland.org. At the top of the page, use the \u201cFind A Drug\u201d tool. Elepsia XR [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[92],"tags":[138],"class_list":["post-7865","post","type-post","status-publish","format-standard","hentry","category-provider-newsletter","tag-formulary-update"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p6ZZHB-22R","_links":{"self":[{"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/posts\/7865","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/comments?post=7865"}],"version-history":[{"count":1,"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/posts\/7865\/revisions"}],"predecessor-version":[{"id":7867,"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/posts\/7865\/revisions\/7867"}],"wp:attachment":[{"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/media?parent=7865"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/categories?post=7865"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/hnetalk.com\/provider\/wp-json\/wp\/v2\/tags?post=7865"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}